Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Addressing the challenge of post-approval regulation of pharmaceuticals

The case for independent third-party evaluations

Bibliographic Data

ID21467896
AuthorsItai Bavli (0000-0002-7323-0435, Bar-Ilan University, corresponding author), Yair Sadaka (0000-0002-4022-4020, Israel Ministry of Health), Chen Yanover (0000-0003-3663-4286, IMI TAMI Institute for Research and Development), Joel Lexchin (0000-0001-5120-8029, York University)
Year2026
Volume167
Pages105585
Publication date2026-05-01
Open AccessYes
TypeARTICLE
VenueHealth Policy (JOURNAL)
Journal identifiersISSN: 0168-8510 • E-ISSN: 1872-6054
PublisherElsevier BV (PUBLISHER)
DOI10.1016/j.healthpol.2026.105585
PMID41724137
OpenAlexW7129434159
LanguageEN
References cited21

MEDLINE · Intellectual Property and Patents · Pharmaceutical Economics and Policy · Regulation and Compliance Studies · Health Policy

  • A comparative analysis of risk management strategies in European Union and United States pharmaceutical regulation

    Courtney Davis, John Abraham et al.•Health Risk & Society•2011

  • Pockets of Weakness in Strong Institutions

    Open Access•Herschel Nachlis•Studies in American Political…•2018

  • The Potential Return on Public Investment in Detecting Adverse Drug Effects

    Krista F Huybrechts, Rishi J Desai et al.•Medical Care•2017

Highly citedNo

Tools

Open DOI
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae